© 2025 MJH Life Sciences™ and The Center for Biosimilars - Biosimilars, Health Economics & Insights. All rights reserved.
Cameron Santoro is an associate editor for The Center for Biosimilars®, The American Journal of Managed Care® (AJMC), and AJMC.com.
March 30, 2025
Article
Josh Canavan, PharmD, RazorMetrics, and Chris O'Dell, Turquoise Health, predict pharmacy benefit managers (PBMs) will evolve toward value-based care, mirroring the broader shift toward open-cost structures.
March 28, 2025
Video
Here are the top 5 biosimilar articles for the week of March 24, 2025.
March 27, 2025
Article
The FDA approved another set of denosumab biosimilars, Conexxence/Bomyntra (denosumab-bnht), expanding treatment options for osteoporosis, bone metastases, and other bone-related conditions, amidst a flurry of similar approvals and legal settlements.
March 25, 2025
Article
Biosimilar natalizumab demonstrated comparable efficacy, safety, and immunogenicity to reference drug Tysabri in patients with relapsing-remitting multiple sclerosis (RRMS), supporting its potential as a cost-effective treatment option.
March 21, 2025
Video
Here are the top 5 biosimilar articles for the week of March 17, 2025.
March 20, 2025
Article
Patients with moderate to severe plaque psoriasis who switched between the adalimumab biosimilar GP2017 and reference adalimumab did not impact immunogenicity, safety, or efficacy following up to 4 switches between both drugs.
March 14, 2025
Video
Here are the top 5 biosimilar articles for the week of March 10, 2025.
March 07, 2025
Video
Here are the top 5 biosimilar articles for the week of March 3, 2025.
February 28, 2025
Video
Here are the top 5 biosimilar articles for the week of February 24, 2025.
February 27, 2025
Article
Patients with non-small cell lung cancer (NSCLC) taking bevacizumab biosimilars demonstrated equivalent therapeutic efficacy and similar safety profiles to those taking the originator product, Avastin.